How To Use HCPCS Code G0429

HCPCS code G0429 describes the use of dermal filler injections for the treatment of facial lipodystrophy syndrome (LDS). This code is specifically used for patients who have developed LDS as a result of highly active antiretroviral therapy. In this article, we will explore the details of HCPCS code G0429, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS G0429?

HCPCS code G0429 is used to identify dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (LDS). It is important to note that this code is specifically applicable to patients who have developed LDS as a result of highly active antiretroviral therapy. The purpose of this code is to ensure accurate documentation and billing for the specific treatment provided to these patients.

2. Official Description

The official description of HCPCS code G0429 is “Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (LDS) (e.g., as a result of highly active antiretroviral therapy).” The short description of this code is “Dermal filler injection(s).” It is crucial to use the exact official and short descriptions when using this code for documentation and billing purposes.

3. Procedure

1. The provider will assess the patient’s facial lipodystrophy syndrome (LDS) and determine the appropriate areas for dermal filler injections.
2. The provider will prepare the dermal filler material according to the manufacturer’s instructions.
3. The provider will cleanse the injection sites with an appropriate antiseptic solution.
4. The provider will use a sterile needle or cannula to inject the dermal filler into the predetermined areas of the patient’s face.
5. The provider will monitor the patient for any adverse reactions or complications following the injections.
6. The provider may provide post-injection instructions to the patient, such as avoiding excessive sun exposure or certain activities that may impact the effectiveness of the dermal filler.

4. When to use HCPCS code G0429

HCPCS code G0429 should be used when performing dermal filler injections for the treatment of facial lipodystrophy syndrome (LDS) in patients who have developed this condition as a result of highly active antiretroviral therapy. It is important to ensure that the patient meets the specific eligibility criteria for this code before using it for documentation and billing purposes.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code G0429, healthcare providers need to ensure that the following documentation requirements are met:

• Medical records should clearly indicate the diagnosis of facial lipodystrophy syndrome (LDS) as a result of highly active antiretroviral therapy.
• Documentation should include the specific areas of the face where the dermal filler injections were administered.
• The type and quantity of dermal filler material used should be documented.
• Any relevant post-injection instructions provided to the patient should be documented.

6. Historical Information and Code Maintenance

HCPCS code G0429 was added to the Healthcare Common Procedure Coding System on March 23, 2010. As of January 01, 2017, there have been no maintenance actions taken for this code, as indicated by the action code N, which means no maintenance for this code. It is important to stay updated with any changes or revisions related to this code to ensure accurate documentation and billing.

7. Medicare and Insurance Coverage

Medicare and insurance coverage for HCPCS code G0429 may vary. It is essential to check with the specific payer to determine if this code is payable and to understand the pricing indicator code and multiple pricing indicator code associated with this code. The pricing indicator code 13 indicates that the price for this service is established by carriers, and the multiple pricing indicator code A means that it is not applicable as HCPCS priced under one methodology.

8. Examples

Here are five examples of when HCPCS code G0429 should be billed:

1. A patient with facial lipodystrophy syndrome (LDS) due to highly active antiretroviral therapy receives dermal filler injections in the cheeks and nasolabial folds.
2. A healthcare provider administers dermal filler injections to a patient with facial lipodystrophy syndrome (LDS) resulting from highly active antiretroviral therapy in the temples and chin.
3. A patient with facial lipodystrophy syndrome (LDS) as a result of highly active antiretroviral therapy undergoes dermal filler injections in the tear troughs and marionette lines.
4. A healthcare provider performs dermal filler injections in the forehead and jawline of a patient with facial lipodystrophy syndrome (LDS) caused by highly active antiretroviral therapy.
5. A patient with facial lipodystrophy syndrome (LDS) due to highly active antiretroviral therapy receives dermal filler injections in the temples, cheeks, and chin.